Beijing Strong Biotechnologies Inc
Beijing Strong Biotechnologies,Inc. researches, develops, manufactures, and sells in-vitro diagnostics (IVD) products and services in China and internationally. The company offers biochemistry reagents, including liver, renal, lipid, cardiac, diabetes, special protein, tumor marker, pancreas, inorganic, inflammation, TDM, and other panels; and coagulation products, such as prothrombin time, activ… Read more
Beijing Strong Biotechnologies Inc (300406) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.046x
Based on the latest financial reports, Beijing Strong Biotechnologies Inc (300406) has a cash flow conversion efficiency ratio of 0.046x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥182.86 Million) by net assets (CN¥4.00 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Strong Biotechnologies Inc - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Beijing Strong Biotechnologies Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Strong Biotechnologies Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Strong Biotechnologies Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CMC Magnetics Corp
TW:2323
|
-0.033x |
|
Xiamen Xindeco Ltd
SHE:000701
|
-0.332x |
|
Tecnon Fujian Commercial Lighting Co Ltd
SHE:300650
|
-0.186x |
|
Mia Teknoloji AS
IS:MIATK
|
0.025x |
|
Shanghai Kindly Entrp Dvlp Grp
SHG:603987
|
0.040x |
|
Berli Jucker PCL
BK:BJC
|
0.035x |
|
Wuhan Sanzhen Industry Holding Co Ltd
SHG:600168
|
-0.051x |
|
Imricor Medical Systems Inc
AU:IMR
|
-0.198x |
Annual Cash Flow Conversion Efficiency for Beijing Strong Biotechnologies Inc (2011–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Strong Biotechnologies Inc from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.13 Billion | CN¥614.01 Million | 0.149x | -6.31% |
| 2023-12-31 | CN¥3.72 Billion | CN¥590.15 Million | 0.159x | +30.84% |
| 2022-12-31 | CN¥3.27 Billion | CN¥396.17 Million | 0.121x | +3.52% |
| 2021-12-31 | CN¥2.91 Billion | CN¥341.10 Million | 0.117x | +225.72% |
| 2020-12-31 | CN¥3.42 Billion | CN¥123.06 Million | 0.036x | -62.44% |
| 2019-12-31 | CN¥1.97 Billion | CN¥188.60 Million | 0.096x | -36.41% |
| 2018-12-31 | CN¥1.70 Billion | CN¥256.15 Million | 0.150x | +10.74% |
| 2017-12-31 | CN¥1.53 Billion | CN¥207.91 Million | 0.136x | -22.45% |
| 2016-12-31 | CN¥1.39 Billion | CN¥243.21 Million | 0.175x | +44.42% |
| 2015-12-31 | CN¥1.18 Billion | CN¥142.59 Million | 0.121x | -23.69% |
| 2014-12-31 | CN¥987.03 Million | CN¥156.94 Million | 0.159x | -48.55% |
| 2013-12-31 | CN¥476.31 Million | CN¥147.19 Million | 0.309x | -5.02% |
| 2012-12-31 | CN¥385.67 Million | CN¥125.49 Million | 0.325x | +104.63% |
| 2011-12-31 | CN¥288.66 Million | CN¥45.90 Million | 0.159x | -- |